Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Marginal Zone Lymphoma
Related studies linked through entity extraction aliases.
Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy
- Status
- RECRUITING
- Phase
- NA
Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma.
- Status
- RECRUITING
- Phase
- PHASE2
A Cohort Study in Newly Diagnosed MZL
- Status
- RECRUITING
- Phase
- N/A
BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Pirtobrutinib in Combination With Rituximab in Adults With Untreated Marginal Zone Lymphoma (PIONEER-MZL)
- Status
- RECRUITING
- Phase
- PHASE2
Rituximab and Zanubrutinib in Patients With Indolent B-cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE2
AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas
- Status
- RECRUITING
- Phase
- PHASE1
Pemigatinib in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Preliminary Assessment of [18F]BL40 in PET/CT Scans
- Status
- COMPLETED
- Phase
- N/A
Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT Study
- Status
- RECRUITING
- Phase
- N/A
[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Mosunetuzumab-Lenalidomide Versus Investigator Choices in Patients With Relapsed or Refractory Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
FT596 in Combination With R-CHOP in Subjects With B-Cell Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1
(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types
- Status
- UNKNOWN
- Phase
- N/A
Obinutuzumab in Combination With Lenalidomide in Relapsed or Refractory Marginal Zone Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
Allo HSCT Using RIC and PTCy for Hematological Diseases
- Status
- RECRUITING
- Phase
- PHASE2